Biotech company Moderna said Thursday that it expects to make almost $20 billion this year from sales of its COVID-19 vaccine — the only product that it has on the market.
Feb.
Home
United States
USA — Financial Moderna says it expects almost $20 billion in COVID-19 vaccine sales in...
Moderna says it expects almost $20 billion in COVID-19 vaccine sales in 2022
